What is NDC 71335-3167?

71335-3167 is the product NDC for Metoprolol succinate, Metoprolol succinate 100 mg/1 tablet, extended release, listed with the FDA by Bryant Ranch Prepack. It has 7 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Metoprolol succinate?

250 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Metoprolol succinate NDC 71335-3167

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-3167Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-3167Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-3167-1	7133531670171335316701	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-1)Marketed from Aug 4, 2026
71335-3167-2	7133531670271335316702	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-2)Marketed from Aug 4, 2026
71335-3167-3	7133531670371335316703	120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-3)Marketed from Aug 4, 2026
71335-3167-4	7133531670471335316704	20 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-4)Marketed from Aug 4, 2026
71335-3167-5	7133531670571335316705	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-5)Marketed from Aug 4, 2026
71335-3167-6	7133531670671335316706	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-6)Marketed from Aug 4, 2026
71335-3167-7	7133531670771335316707	10 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-7)Marketed from Aug 4, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metoprolol succinate
Generic name (nonproprietary): metoprolol succinate
Active ingredients: Metoprolol succinate — 100 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214110
Marketing start: Jul 21, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 71335-3167_ccca9f4b-3d0f-467a-a4a7-8505fae57d0eSPL ID ccca9f4b-3d0f-467a-a4a7-8505fae57d0eSPL set ID a693bef9-cdfa-4012-ac87-873b9c5bf1cdRxCUI 866412UNII TH25PD4CCB
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335316701 followed by a unit qualifier and the quantity

Package 71335-3167-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 4, 2026.

Indications (excerpt from the label)

Metoprolol succinate, is a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure ( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These b…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-3167

What is NDC 71335-3167?: 71335-3167 is the product NDC for Metoprolol succinate, Metoprolol succinate 100 mg/1 tablet, extended release, listed with the FDA by Bryant Ranch Prepack. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Metoprolol succinate.
What is the active ingredient?: Metoprolol succinate.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Metoprolol succinate?: 250 other product NDCs are listed under this name. See all Metoprolol succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Metoprolol succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Metoprolol Succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-0883	67046-0883-03
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1685	67046-1685-03
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1686	67046-1686-03
Metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Oryza pharmaceuticals Inc.	72516-025	72516-0025-0172516-0025-1072516-0025-50
Metoprolol Succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-684	68001-0684-0068001-0684-03
Metoprolol Succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-685	68001-0685-0068001-0685-03
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-686	68001-0686-0068001-0686-03
Metoprolol Succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-687	68001-0687-00
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1650	67046-1650-03
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	53401-009	53401-0009-3053401-0009-4553401-0009-53+3 more

All 251 Metoprolol succinate NDCs

Other NDCs under ANDA 214110

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214110
Product	Strength	Form · route	Labeler	Product NDC
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1685
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Zhejiang Jutai Pharamceutical Co., Ltd	71765-006
Metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	Zhejiang Jutai Pharamceutical Co., Ltd	71765-007
Metoprolol succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	Zhejiang Jutai Pharamceutical Co., Ltd	71765-008
Metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Oryza pharmaceuticals Inc.	72516-025
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Oryza pharmaceuticals Inc.	72516-026
Metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	Oryza pharmaceuticals Inc.	72516-027
Metoprolol succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	Oryza pharmaceuticals Inc.	72516-028